As Roche Sequencing Solutions looks forward to meeting tomorrow’s biggest needs in genomics, it’s clear that today’s sequencing technologies face several limitations that impact growing needs for faster speed, improved accuracy, greater scalability, and increased flexibility.
Some traditional sequencing technologies leverage a cycle-based approach for measuring the bases of the DNA, which delays access to usable data. While on-market single-molecule nanopore technology addresses this challenge, it can be limited by fundamental signal-to-noise limitations—a result of poor spatial resolution and molecular distinction of nucleobases.